Insider Stock Trading History of Colonnese Mark P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Colonnese Mark P since year 2005. The trader's CIK number is 1040766. At the time of this reporting, Colonnese Mark P is the Chief Financial Officer of Nabi Biopharmaceuticals . (stock ticker symbol NABI). See this page for all insider trading activities at Nabi Biopharmaceuticals .

Note that in the past COLONNESE MARK P also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Colonnese Mark P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-02-09 BOTA Nabi Biopharmaceuticals Buy 7,000 1.40 9,814
2007-03-20 AGIX Atherogenics Inc Option Ex 25,000 .38 9,500
2005-12-27 AGIX Atherogenics Inc Sale 100,000 21.35 2,135,000
2005-12-27 AGIX Atherogenics Inc Option Ex 100,000 .33 33,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Colonnese Mark P (Chief Financial Officer of Nabi Biopharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.